THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Market cap: $285.0M (2/09/2026)
Price: $3.33
Larimar Therapeutics Enters Exchange Agreement for Preferred Stock
Investor Presentation
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report